UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 24,
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Navidea Biopharmaceuticals Charts.
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Navidea Biopharmaceuticals Charts.

Navidea Biopharmaceuticals, Inc. News

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Thursday 21 December 2023 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 1 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 16 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Monday 23 October 2023 (6 months ago) • Edgar (US Regulatory)
Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
Thursday 5 October 2023 (7 months ago) • Business Wire
Form DEF 14A - Other definitive proxy statements
Thursday 5 October 2023 (7 months ago) • Edgar (US Regulatory)
Form PRE 14A - Other preliminary proxy statements
Friday 15 September 2023 (8 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Sunday 10 September 2023 (8 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Tuesday 15 August 2023 (9 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 11 August 2023 (9 months ago) • Edgar (US Regulatory)
Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel
Thursday 10 August 2023 (9 months ago) • Business Wire

More Navidea Biopharmaceuticals, Inc. News Articles